Eye News and Research

Latest Eye News and Research

AAO recognizes outstanding eye physicians and surgeons for innovation in patient care

The American Academy of Ophthalmology will pay tribute to outstanding eye physicians and surgeons who have made significant achievements in various areas of the profession. These range from scientific innovation and humanitarian service to education and advocacy. The honorees will be recognized AAO 2015, the Academy's 119th annual meeting in Las Vegas.

13 Nov 2015

AAO announces launch of new online resource to improve eye care for children

The American Academy of Ophthalmology today announced the launch of a new online resource for eye physicians and surgeons dedicated solely to children's ocular diseases and disorders. The Knights Templar Eye Foundation Pediatric Ophthalmology Education Center is an important tool that enables ophthalmologists to better serve the 19 million children worldwide who suffer visual impairment. The new resource will be unveiled this week at AAO 2015, the 119th annual meeting of the American Academy of Ophthalmology.

12 Nov 2015

Special orchestra boosts mood and confidence in patients with dementia

A special orchestra for people with dementia has helped boost their confidence and mood, according to a new research project.

11 Nov 2015

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Using intensive treatment to lower blood pressure below currently recommended targets significantly reduces rates of major cardiovascular events like stroke and heart attack among a wide range of high-risk patients, according to a large meta-analysis involving almost 45000 individuals, published in The Lancet.

11 Nov 2015

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).

10 Nov 2015

L-DOPA drug may delay or prevent age-related macular degeneration

A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million older Americans - age-related macular degeneration (AMD).

10 Nov 2015

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Digital Surgical Simulator Touch Surgery Collaborates with Experts Surgeons at International Institutions (Stanford, Yale, Dartmouth, Vanderbilt, Imperial College London, Singapore National Eye Center & Others) to Create Simulations of Surgical Best Practices.

6 Nov 2015

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

The capabilities of the OPMI® PENTERO® 800 surgical microscopes from ZEISS for reconstructive surgery have been enhanced by the introduction of the INFRARED 800 module.

From Carl Zeiss Microscopy GmbH 6 Nov 2015

UCSF scientists identify eye drop chemical that may reverse cataracts

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

6 Nov 2015

Boxing more dangerous than mixed martial arts, shows study

Mixed martial arts has a reputation for being one of the most brutal and bloody of all contact sports, but the reality is boxing poses a greater risk of serious injury, according to new research from the University of Alberta.

6 Nov 2015

Men exposed to domestic violence more worried about not being believed

Men who receive help from crisis centres are mostly satisfied with the help they get. But they fear that nobody will believe that they've been abused by a woman.

6 Nov 2015

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.

5 Nov 2015

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

A team of UConn biomedical engineers, working with colleagues from Yale, MIT, and Harvard, has developed a simple, inexpensive, and quick technique for the diagnosis and monitoring of sickle cell disease that can be used in regions where advanced medical technology and training are scarce.

5 Nov 2015

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.

5 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

ZEISS adds INFRARED 800 to OPMI PENTERO 800 for reconstructive surgery

ZEISS is now adding INFRARED 800 to its OPMI PENTERO 800 surgical microscope for reconstructive surgery. The new enhancements are tailored to the requirements of breast reconstruction, lymph supermicrosurgery, and oral and maxillofacial surgery. Clinical specialists can benefit from the optimized package of ZEISS OPMI PENTERO 800 which provides intraoperative assessment of blood flow, higher magnification and effortless maneuverability required for complex reconstructive surgery.

4 Nov 2015

Good news for patients suffering from dry age-related macular degeneration

Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.

3 Nov 2015

Study identifies potential new approaches to curing parasitic diseases

A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

3 Nov 2015

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

3 Nov 2015

Eye News and Research

Latest Eye News and Research

AAO recognizes outstanding eye physicians and surgeons for innovation in patient care

AAO announces launch of new online resource to improve eye care for children

Special orchestra boosts mood and confidence in patients with dementia

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

L-DOPA drug may delay or prevent age-related macular degeneration

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

UCSF scientists identify eye drop chemical that may reverse cataracts

Boxing more dangerous than mixed martial arts, shows study

Men exposed to domestic violence more worried about not being believed

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

ZEISS adds INFRARED 800 to OPMI PENTERO 800 for reconstructive surgery

Good news for patients suffering from dry age-related macular degeneration

Study identifies potential new approaches to curing parasitic diseases

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Eye News and Research

Latest Eye News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in